These data clearly indicate that both CHT and aging play synergic roles in the regulation of Vδ2pos T cell homeostasis in CLM patients with the final result of greatly accelerating their terminal differentiation towards a senescent CD57pos/TEMRA subset highly impaired in its anti-tumor effector-functions. This evidence concerns the gene SLC5A7 and neoplasm.